HY-P1117-1mg
|
MedChemexpress LLC
|
MMK1 [CAS 271246-66-3]
|
|
COVID-19-immunoregulation
|
|
HY-122624-10mg
|
MedChemexpress LLC
|
MMP13-IN-2 [CAS 935759-55-0]
|
|
COVID-19-immunoregulation
|
|
HY-122624-100mg
|
MedChemexpress LLC
|
MMP13-IN-2 [CAS 935759-55-0]
|
|
COVID-19-immunoregulation
|
|
HY-122624-25mg
|
MedChemexpress LLC
|
MMP13-IN-2 [CAS 935759-55-0]
|
|
COVID-19-immunoregulation
|
|
HY-122624-5mg
|
MedChemexpress LLC
|
MMP13-IN-2 [CAS 935759-55-0]
|
|
COVID-19-immunoregulation
|
|
HY-122624-50mg
|
MedChemexpress LLC
|
MMP13-IN-2 [CAS 935759-55-0]
|
|
COVID-19-immunoregulation
|
|
HY-122624-1mL
|
MedChemexpress LLC
|
MMP13-IN-2 [CAS 935759-55-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-120824-10mg
|
MedChemexpress LLC
|
Mofezolac [CAS 78967-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-120824-100mg
|
MedChemexpress LLC
|
Mofezolac [CAS 78967-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-120824-25mg
|
MedChemexpress LLC
|
Mofezolac [CAS 78967-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-120824-5mg
|
MedChemexpress LLC
|
Mofezolac [CAS 78967-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-120824-50mg
|
MedChemexpress LLC
|
Mofezolac [CAS 78967-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-120824-1mL
|
MedChemexpress LLC
|
Mofezolac [CAS 78967-07-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|